Tweenvest Stocks

LENZ Therapeutics, Inc. (NasdaqGS: LENZ)

Health Care · Pharmaceuticals · US

$3.53

-2.49% today · -92.7% 1Y

LENZ Therapeutics, Inc. (NasdaqGS: LENZ) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $110.91M and employs 152 people.

Over the last twelve months the share price has lost 92.7%, trading between 3.51 and 49.85.

Tweenvest scores LENZ Therapeutics, Inc. across four factors: quality 43/100, value 40/100. Its strongest factor is quality.

LENZ price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$110.91M
Revenue (TTM)
$21.48M
P/E
—
EPS
-4.12
Dividend yield
—
Beta (5Y)
1.73
52-week high
$49.85
52-week low
$3.51
Avg volume (3M)
—
Shares outstanding
31.42M
Employees
152
Next earnings
—

About LENZ Therapeutics, Inc.

LENZ Therapeutics, Inc. is a biopharmaceutical firm whose primary mission involves the advancement and commercialization of new treatments designed to enhance vision for individuals in the United States. The company's portfolio features two investigational products, LNZ100 and LNZ101, both of which are currently undergoing late-stage Phase III clinical trials as potential solutions for presbyopia. Corporate operations for LENZ Therapeutics are situated in Del Mar, California.

ISIN
US52635N1037
Founded
2013
Listed since
Jun 25, 2021
Exchange
Nasdaq Global Select
Currency
USD
CompanyMarket capPriceDay
Bajaj HealthCare LimitedBSE: 539872$113.07MRs323.40-6.07%
Daihan Pharmaceutical Co.,Ltd.KOSDAQ: A023910$113.06M₩25,850.00-0.19%
Sigachi Industries LimitedNSEI: SIGACHI$112.48MRs28.34-3.70%
Curatis Holding AGSWX: CURN$112.13MCHF17.50-8.62%
Kyung Dong Pharmaceutical Co., Ltd.KOSDAQ: A011040$109.21M₩5,020.00-0.20%
Themis Medicare LimitedBSE: 530199$109.15MRs114.10-2.56%
Jeil Pharmaceutical Co.,LtdKOSE: A271980$108.20M₩10,000.00+0.30%
Ilyang Pharmaceutical Co.,LtdKOSE: A007570$107.54M₩8,080.00+4.66%

Browse every Pharmaceuticals company →

Figures last refreshed Oct 4, 2026.